Q-omics provides the consensus-scored USP17L6P profile across patient tissues and cancer cell-line models. USP17L6P expression is associated with patient survival in 6 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, USP17L6P RNA expression shows 3,991 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight STAD, and BRCA as cancer lineages where USP17L6P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.